What is BriaCell Therapeutics Corp. Warrant expiring 2031's Enterprise Value?

BriaCell Therapeutics Corp. Warrant expiring 2031's Enterprise Value is -$14.6M, based on as-reported figures from SEC (XBRL) filings.

What is BriaCell Therapeutics Corp. Warrant expiring 2031's Net Income (TTM)?

BriaCell Therapeutics Corp. Warrant expiring 2031's Net Income (TTM) is -$30.7M, based on as-reported figures from SEC (XBRL) filings.

What is BriaCell Therapeutics Corp. Warrant expiring 2031's Diluted EPS (TTM)?

BriaCell Therapeutics Corp. Warrant expiring 2031's Diluted EPS (TTM) is -3.53, based on as-reported figures from SEC (XBRL) filings.

BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL) Financial Statements

BriaCell Therapeutics Corp. Warrant expiring 2031

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI AK-412096DA5B

XNAS · usd

0.94▼ 0.01 (-0.75%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close0.95

Day's Range0.93 – 0.99

52-Week Range0.61 – 1.40

Volume19.9K

Avg Volume9,834

Share Statistics

Shares Outstanding

Employees4

ExchangeXNAS

Listed2026-01-14

Share count as of June 9, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL)

What is BriaCell Therapeutics Corp. Warrant expiring 2031's Market Cap?: BriaCell Therapeutics Corp. Warrant expiring 2031's Market Cap is $8.2M, based on as-reported figures from SEC (XBRL) filings.
What is BriaCell Therapeutics Corp. Warrant expiring 2031's Enterprise Value?: BriaCell Therapeutics Corp. Warrant expiring 2031's Enterprise Value is -$14.6M, based on as-reported figures from SEC (XBRL) filings.
What is BriaCell Therapeutics Corp. Warrant expiring 2031's EV / EBITDA?: BriaCell Therapeutics Corp. Warrant expiring 2031's EV / EBITDA is 0.5×, based on as-reported figures from SEC (XBRL) filings.
What is BriaCell Therapeutics Corp. Warrant expiring 2031's Net Income (TTM)?: BriaCell Therapeutics Corp. Warrant expiring 2031's Net Income (TTM) is -$30.7M, based on as-reported figures from SEC (XBRL) filings.
What is BriaCell Therapeutics Corp. Warrant expiring 2031's EBITDA?: BriaCell Therapeutics Corp. Warrant expiring 2031's EBITDA is -$31.9M, based on as-reported figures from SEC (XBRL) filings.
What is BriaCell Therapeutics Corp. Warrant expiring 2031's Diluted EPS (TTM)?: BriaCell Therapeutics Corp. Warrant expiring 2031's Diluted EPS (TTM) is -3.53, based on as-reported figures from SEC (XBRL) filings.
What is BriaCell Therapeutics Corp. Warrant expiring 2031's Net Debt?: BriaCell Therapeutics Corp. Warrant expiring 2031's Net Debt is -$22.8M, based on as-reported figures from SEC (XBRL) filings.